Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Short term Debt (2009 - 2024)

Grifols' (GIFLF) quarterly Short term Debt came in at $722.5 million in Q4 2024, down 34.4% on a YoY basis from $1.1 billion in Q1 2024, and down 34.4% quarter-over-quarter from $1.1 billion in Q4 2023.

Analysis

Grifols (GIFLF) Short term Debt (2009 - 2024) Analysis & Trends

Grifols (GIFLF) has reported Short term Debt for 16 consecutive years, with $722.5 million the latest figure, recorded in Q4 2024.

  • For the quarter ending Q4 2024, Short term Debt fell 34.4% year-over-year to $722.5 million; the trailing twelve-month figure through Dec 2024 stood at $722.5 million (down 34.4% YoY), and the FY2024 full-year result was $722.5 million, down 34.4% from the prior year.
  • Short term Debt eased to $722.5 million in Q4 2024 per GIFLF's latest filing, from $1.1 billion in the prior quarter.
  • Across five years, Short term Debt topped out at $2.8 billion in Q4 2021 and bottomed at $365.9 million in Q1 2020.
  • Historically, Short term Debt has averaged $953.0 million across 5 years, with a median of $722.5 million in 2024.
  • The sharpest annual moves came in 2021 and 2022: Short term Debt surged 450.97% in 2021, then slumped 70.9% in 2022.
  • Over 5 years, Short term Debt stood at $506.3 million in 2020, then surged by 450.97% to $2.8 billion in 2021, then plunged by 70.9% to $811.8 million in 2022, then surged by 35.67% to $1.1 billion in 2023, then plunged by 34.4% to $722.5 million in 2024.
  • According to Business Quant data, Short term Debt over the past three periods registered $722.5 million, $1.1 billion, and $811.8 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 722.46 Mn
Dec 31, 2023 1.10 Bn
Dec 31, 2022 811.80 Mn
Dec 31, 2021 2.79 Bn
Dec 31, 2020 506.26 Mn
Sep 30, 2020 373.69 Mn
Mar 31, 2020 365.85 Mn
Dec 31, 2019 399.93 Mn
Sep 30, 2019 462.26 Mn
Dec 31, 2018 316.60 Mn
Sep 30, 2018 287.95 Mn
Jun 30, 2018 244.77 Mn
Mar 31, 2018 405.38 Mn
Dec 31, 2017 182.58 Mn
Jun 30, 2017 163.35 Mn
Dec 31, 2016 248.41 Mn
Sep 30, 2016 248.78 Mn
Jun 30, 2016 243.09 Mn
Mar 31, 2016 15.11 Mn
Dec 31, 2015 287.73 Mn